Corrigendum to "XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy" [Biomed. Pharmacother. 120 (2019) 109519].
作者信息
Wang Neng, Yang Bowen, Muhetaer Gulizeba, Wang Shengqi, Zheng Yifeng, Lu Jiahong, Li Min, Zhang Fengxue, Situ Honglin, Lin Yi, Wang Zhiyu
机构信息
Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China.
Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China; Post-doctoral Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
出版信息
Biomed Pharmacother. 2022 May;149:112867. doi: 10.1016/j.biopha.2022.112867. Epub 2022 Mar 31.
Zotero 插件